Information Provided By:
Fly News Breaks for December 14, 2015
BMY
Dec 14, 2015 | 08:28 EDT
Cowen raised its price target on Bristol-Myers to $100 from $75 and calls it a Best Idea for 2016, as it sees the company continuing to ride the crest of the immune-oncology wave. Cowen, which noted estimates have increased and that the company's position in immune-oncology remains firm, reiterated its Outperform rating on Bristol-Myers shares.
News For BMY From the Last 2 Days
There are no results for your query BMY